Affinity Capital Management logo

Affinity Capital Management

North America, Minnesota, United States, Minneapolis

Description

Affinity Capital Management is a well-established venture capital firm based in Minneapolis, Minnesota, specializing in investments within the healthcare sector. The firm's investment strategy is sharply focused on healthcare technology, encompassing a broad range of sub-sectors including medical devices, diagnostics, healthcare information technology, and healthcare services. With a history spanning several decades, Affinity Capital has cultivated deep expertise and an extensive network within the complex healthcare ecosystem, positioning itself as a strategic partner for innovative companies.

The firm primarily targets companies that are beyond the initial seed stage but have not yet reached profitability, typically engaging in Series B or Series C funding rounds. Affinity Capital seeks businesses with proven technologies, clear market opportunities, and strong, experienced management teams capable of executing their growth strategies. Their investment philosophy emphasizes providing growth capital to help these companies scale operations, expand market reach, and navigate regulatory pathways. The firm manages over $200 million in capital across multiple funds, indicating their capacity to support significant growth initiatives.

Affinity Capital's typical first cheque size ranges from approximately $2 million to $10 million, reflecting their focus on providing substantial growth equity to developing healthcare ventures. This capital is often deployed to support product commercialization, clinical trials, or market expansion efforts. To date, Affinity Capital Management has invested in over 30 companies, building a diverse portfolio of healthcare innovators. Beyond financial investment, the firm actively leverages its industry knowledge and connections to provide strategic guidance, operational support, and access to key opinion leaders, aiming to accelerate the success of its portfolio companies.

Investor Profile

Affinity Capital Management has backed more than 42 startups, with 0 new investments in the last 12 months alone. The firm has led 8 rounds, about 19% of its total and boasts 12 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Series D rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Health Care, Medical Device, Medical.
  • Typical check size: $2M – $10M.

Stage Focus

  • Series C (29%)
  • Series B (21%)
  • Series D (19%)
  • Series E (10%)
  • Series A (10%)
  • Series Unknown (10%)
  • Series F (2%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Medical Device
  • Medical
  • Biotechnology
  • Therapeutics
  • Health Diagnostics
  • Developer Platform
  • Clinical Trials
  • Wireless
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Affinity Capital Management frequently co-invest with?

Baird Capital
North America, Wisconsin, United States, Milwaukee
Co-Investments: 5
ONSET Ventures
North America, California, United States, Menlo Park
Co-Investments: 8
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 6
Three Arch Partners
North America, California, United States, Portola Valley
Co-Investments: 11
Alloy Ventures
North America, California, United States, Palo Alto
Co-Investments: 5
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 5
GBS Ventures
Oceania, Victoria, Australia, Melbourne
Co-Investments: 6
Delphi Ventures
North America, California, United States, San Mateo
Co-Investments: 13
SightLine Partners
North America, Minnesota, United States, Minneapolis
Co-Investments: 4
Prism Venture Management
North America, Massachusetts, United States, Needham
Co-Investments: 7

Which angels does Affinity Capital Management often collaborate with?

Shared Deals: 1
SR
North America, California, United States, Palo Alto
Shared Deals: 1

What are some of recent deals done by Affinity Capital Management?

ExplORer Surgical

Chicago, Illinois, United States

ExplORer is an interactive surgical playbook that promotes optimal teamwork in the operating room.

Clinical TrialsHealth CareHospitalMedical DeviceSoftware
Series AApr 18, 2019
Amount Raised: $5,000,000
Respicardia

Minnetonka, Minnesota, United States

Respicardia develops implantable therapies to improve respiratory and cardiovascular health.

Health CareMedical DeviceTherapeutics
Series DSep 4, 2013
Amount Raised: $10,000,006
Sonitus Medical

San Mateo, California, United States

Sonitus Medical provides clinically effective non-invasive and removable hearing solutions based on the bone conduction method.

Health CareInformation TechnologyMedical Device
Series DMay 15, 2012
Amount Raised: $25,000,000
Uptake Medical

Seattle, Washington, United States

Uptake Medical develops innovative technologies for the treatment of lung diseases.

BiotechnologyHealth CareMedical
Series CMar 13, 2012
Amount Raised: $40,259,226
iScience Interventional

Menlo Park, California, United States

iScience Interventional provides microcatheter and imaging technologies for ophthalmologists to deliver site-specific ocular therapies.

BiotechnologyHealth CareHealth Diagnostics
Series UnknownJan 27, 2012
Amount Raised: $2,759,185
Celleration

Eden Prairie, Minnesota, United States

Celleration is a medical device company developing and commercializing therapeutic ultrasound platforms.

Health CareMedicalMedical DeviceTherapeutics
Series EJan 12, 2011
Amount Raised: $8,000,000
Respicardia

Minnetonka, Minnesota, United States

Respicardia develops implantable therapies to improve respiratory and cardiovascular health.

Health CareMedical DeviceTherapeutics
Series CAug 25, 2010
Amount Raised: $27,000,000
Uptake Medical

Seattle, Washington, United States

Uptake Medical develops innovative technologies for the treatment of lung diseases.

BiotechnologyHealth CareMedical
Series BJul 7, 2010
Amount Raised: $17,500,000
Baxano

San Jose, California, United States

Baxano develops minimally-invasive tools to restore spine function and preserve healthy tissues.

BiotechnologyHealth CareMedical Device
Series CJun 23, 2010
Amount Raised: $30,000,000
Anulex Technologies

Minnetonka, Minnesota, United States

Anulex Technologies develops technologies and surgical techniques to improve the treatment of herniated discs.

BiotechnologyHealth CareMedicalMedical Device
Series EJun 7, 2010
Amount Raised: $18,300,000